{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:28:29Z","timestamp":1789421309842,"version":"build-2803163510"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"abstract":"<jats:p>Objective. It has been demonstrated clearly that sweet-tasting solutions given before a painful intervention can reduce pain among newborns. There is no fully accepted explanation for this effect, but activation of endogenous opioids has been suggested as a possible mechanism. The aim of this study was to obtain deeper knowledge of the underlying mechanism by investigating whether administration of an opioid antagonist would reduce the effect of orally administered glucose at heel stick among term newborns.<\/jats:p>\n               <jats:p>Design. A randomized, placebo-controlled, double-blind trial with a validated, neonatal, pain-rating scale.<\/jats:p>\n               <jats:p>Participants. The trial included 30 term newborns undergoing heel stick, who were assigned randomly to 1 of 2 groups, ie, group I, with naloxone hydrochloride (opioid antagonist) 0.01 mg\/kg administered intravenously before oral administration of 1 mL of 30% glucose, or group II, with a corresponding amount of placebo (saline solution) administered intravenously before oral administration of glucose.<\/jats:p>\n               <jats:p>Outcome Measures. Pain-related behavior during blood sampling was measured with the Premature Infants Pain Profile. Crying time and heart rate were also recorded.<\/jats:p>\n               <jats:p>Results. The 2 groups did not differ significantly in Premature Infant Pain Profile scores during heel stick. The median crying time during the first 3 minutes was 14 seconds (range: 0\u2013174 seconds) for the naloxone group and 105 seconds (range: 0\u2013175 seconds) for the placebo group. There was no significant difference in heart rate between the 2 groups.<\/jats:p>\n               <jats:p>Conclusion. Administration of an opioid antagonist did not decrease the analgesic effect of orally administered glucose given before blood sampling.<\/jats:p>","DOI":"10.1542\/peds.2004-1189","type":"journal-article","created":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T18:03:40Z","timestamp":1112378620000},"page":"1004-1007","source":"Crossref","is-referenced-by-count":75,"title":["The Role of Endogenous Opioids in Mediating Pain Reduction by Orally Administered Glucose Among Newborns"],"prefix":"10.1542","volume":"115","author":[{"given":"Maria","family":"Gradin","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, O\u0308rebro University Hospital, O\u0308rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schollin","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, O\u0308rebro University Hospital, O\u0308rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,4,1]]},"reference":[{"key":"2021120819263247800_R1","doi-asserted-by":"crossref","unstructured":"Stevens B, Yamada J, Ohlsson A. Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev.2004(3):CD001069","DOI":"10.1002\/14651858.CD001069.pub2"},{"key":"2021120819263247800_R2","doi-asserted-by":"crossref","unstructured":"Carbajal R, Chauvet X, Couderc S, Olivier-Martin M. Randomised trial of analgesic effects of sucrose, glucose, and pacifiers in term neonates. BMJ.\u20081999;319:1393\u20131397","DOI":"10.1136\/bmj.319.7222.1393"},{"key":"2021120819263247800_R3","doi-asserted-by":"crossref","unstructured":"Carbajal R, Lenclen R, Gajdos V, Jugie M, Paupe A. Crossover trial of analgesic efficacy of glucose and pacifier in very preterm neonates during subcutaneous injections. Pediatrics.\u20082002;110:389\u2013393","DOI":"10.1542\/peds.110.2.389"},{"key":"2021120819263247800_R4","doi-asserted-by":"crossref","unstructured":"Eriksson M, Gradin M, Schollin J. Oral glucose and venepuncture reduce blood sampling pain in newborns. Early Hum Dev.\u20081999;55:211\u2013218","DOI":"10.1016\/S0378-3782(99)00018-3"},{"key":"2021120819263247800_R5","doi-asserted-by":"crossref","unstructured":"Gradin M, Eriksson M, Holmqvist G, Holstein A, Schollin J. Pain reduction at venipuncture in newborns: oral glucose compared with local anesthetic cream. Pediatrics.\u20082002;110:1053\u20131057","DOI":"10.1542\/peds.110.6.1053"},{"key":"2021120819263247800_R6","doi-asserted-by":"crossref","unstructured":"Johnston CC, Stremler R, Horton L, Friedman A. Effect of repeated doses of sucrose during heel stick procedure in preterm neonates. Biol Neonate.\u20081999;75:160\u2013166","DOI":"10.1159\/000014092"},{"key":"2021120819263247800_R7","doi-asserted-by":"crossref","unstructured":"Skogsdal Y, Eriksson M, Schollin J. Analgesia in newborns given oral glucose. Acta Paediatr.\u20081997;86:217\u2013220","DOI":"10.1111\/j.1651-2227.1997.tb08872.x"},{"key":"2021120819263247800_R8","unstructured":"Larsson BA, Gradin M, Lind V, Selander B. Swedish guidelines for prevention and treatment of pain in the newborn infant [in Swedish]. Lakartidningen.\u20082002;99:1946\u20131949"},{"key":"2021120819263247800_R9","doi-asserted-by":"crossref","unstructured":"Anand KJ, International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med.\u20082001;155:173\u2013180","DOI":"10.1001\/archpedi.155.2.173"},{"key":"2021120819263247800_R10","doi-asserted-by":"crossref","unstructured":"Blass EM, Shah A. Pain-reducing properties of sucrose in human newborns. Chem Senses.\u20081995;20:29\u201335","DOI":"10.1093\/chemse\/20.1.29"},{"key":"2021120819263247800_R11","doi-asserted-by":"crossref","unstructured":"Blass EM, Ciaramitaro V. A new look at some old mechanisms in human newborns: taste and tactile determinants of state, affect, and action. Monogr Soc Res Child Dev.\u20081994;59:1\u201381","DOI":"10.2307\/1166096"},{"key":"2021120819263247800_R12","doi-asserted-by":"crossref","unstructured":"Blass E, Fitzgerald E, Kehoe P. Interactions between sucrose, pain and isolation distress. Pharmacol Biochem Behav.\u20081987;26:483\u2013489","DOI":"10.1016\/0091-3057(87)90153-5"},{"key":"2021120819263247800_R13","unstructured":"La\u0308kemedelsindustrifo\u0308reningen. FASS: Fo\u0308rteckning O\u0308ver Humanla\u0308kemedel 2003 [Swedish Drug Information]. Stockholm, Sweden: La\u0308kemedelsindustrifo\u0308reningen; 2003"},{"key":"2021120819263247800_R14","unstructured":"Pocock S. Clinical Trials: A Practical Approach. Chichester, United Kingdom: John Wiley & Sons; 1983"},{"key":"2021120819263247800_R15","doi-asserted-by":"crossref","unstructured":"Taddio A, Shah V, Shah P, Katz J. \u03b2-Endorphin concentration after administration of sucrose in preterm infants. Arch Pediatr Adolesc Med.\u20082003;157:1071\u20131074","DOI":"10.1001\/archpedi.157.11.1071"},{"key":"2021120819263247800_R16","doi-asserted-by":"crossref","unstructured":"Eriksson M, Finnstro\u0308m O. Can daily repeated doses of orally administered glucose induce tolerance when given for neonatal pain?Acta Paediatr.\u20082004;93:246\u2013249","DOI":"10.1111\/j.1651-2227.2004.tb00714.x"},{"key":"2021120819263247800_R17","doi-asserted-by":"crossref","unstructured":"Levine J, Gordon N, Fields H. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature.\u20081979;278:740\u2013741","DOI":"10.1038\/278740a0"},{"key":"2021120819263247800_R18","doi-asserted-by":"crossref","unstructured":"Woolf C. Analgesia and hyperalgesia produced in the rat by intrathecal naloxone. Brain Res.\u20081980;189:593\u2013597","DOI":"10.1016\/0006-8993(80)90375-3"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/4\/1004\/1176397\/zpe00405001004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/4\/1004\/1176397\/zpe00405001004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T20:45:21Z","timestamp":1638996321000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/4\/1004\/67550\/The-Role-of-Endogenous-Opioids-in-Mediating-Pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4,1]]},"published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-1189","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}